These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8205042)

  • 41. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat.
    Justicia C; Pérez-Asensio FJ; Burguete MC; Salom JB; Planas AM
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1097-104. PubMed ID: 11524614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The neuroprotective effect of GABA-ergic substances in cerebral ischemia].
    Kulinskiĭ VI; Mikhel'son GV
    Eksp Klin Farmakol; 1997; 60(1):56-8. PubMed ID: 9162288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
    Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytochrome C in the treatment of patients in the acute stage of ischemic strokes].
    Zinchenko VA
    Vrach Delo; 1985 Jul; (7):83-4. PubMed ID: 2996234
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of cerebrocrast on local cerebral circulation and EEG in awake rats in cerebral ischemia].
    Plotnikov MB; Vaizova OE; Suslov NI
    Biull Eksp Biol Med; 1995 Mar; 119(3):296-8. PubMed ID: 7795201
    [No Abstract]   [Full Text] [Related]  

  • 47. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Gatsura VV; Smirnov LD
    Eksp Klin Farmakol; 1999; 62(5):15-7. PubMed ID: 10572744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of succinate combined with cytochrome C on postischemic disorders in the skeletal muscle of the extremities].
    Kostnikova IV; Ovchinnikov IV
    Eksp Klin Farmakol; 1995; 58(2):42-3. PubMed ID: 7773089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ineffectiveness of cytochrome c on experimental death angel poisoning].
    Siegers CP; Strubelt O
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1779-81. PubMed ID: 4355087
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacological correction of cerebral circulation in experimental acute myocardial ischemia].
    Miller LG
    Farmakol Toksikol; 1983; 46(2):62-5. PubMed ID: 6852220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cerebrovascular effects of GABA-prostaglandin E2 conjugate in comparison with prostaglandin E2].
    Gorbunova AV; Gan'shina TS; Gretskaia NM; Bezuglov VV; Mirzoian RS
    Eksp Klin Farmakol; 2013; 76(8):13-6. PubMed ID: 24228482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of cytochrome C, sulnate and contrical on a change in the blood coagulating system and fibrinolysis during blood flow recovery in ischemic extremities].
    Levandovskiĭ IV; Shal'nev AN
    Patol Fiziol Eksp Ter; 1979; (6):26-9. PubMed ID: 94430
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative study of several preparations in different models of cerebral hypoxia].
    Ivanova IA; Bobkov IuG
    Biull Eksp Biol Med; 1984 Nov; 98(11):567-70. PubMed ID: 6509174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of the early homeostatic disorders by using cytochrome C, a sodium persulfate preparation and contrical in tourniquet shock].
    Levandovskiĭ IV; Epishin IuN
    Anesteziol Reanimatol; 1981; (3):60-3. PubMed ID: 6170237
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of cytochrome C on the cerebral blood flow and metabolism.
    Lee TK; Yu H; Wang YH; Chen YH; Liaw H
    Taiwan Yi Xue Hui Za Zhi; 1975 Mar; 74(3):185-90. PubMed ID: 167100
    [No Abstract]   [Full Text] [Related]  

  • 56. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
    Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG
    Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of thermography and ultrasound dopplerography for evaluating efficacy of complamin in the treatment of patients with disorders of cerebral circulation].
    Kozlova EN; Nikitin IuM; Strel'tsova EN
    Klin Med (Mosk); 1981 Sep; 59(9):38-42. PubMed ID: 7311428
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative evaluation of the neuroprotective activity of phenibut and piracetam under experimental cerebral ischemia conditions in rats].
    Tiurenkov IN; Bagmetov MN; Epishina VV; Borodkina LE; Voronkov AV
    Eksp Klin Farmakol; 2006; 69(3):19-22. PubMed ID: 16878492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prolongation of safe periods in brain ischemia].
    Tel'pukhov VI; Trenin SO; Kniazeva GD; Lapkina TI
    Vestn Akad Med Nauk SSSR; 1985; (4):65-71. PubMed ID: 4013512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.